ABSTRACT Among the medicinal purposes for which plants have been used is the treatment of “nerves". The objective of this study was to search for species of plants used in the state of Rio Grande do Sul (South Brazil) for the relief of symptoms related to central nervous system (CNS) disorders. Twenty-seven ethnobotanical studies were compiled, in which a total of 94 species were cited. The five most cited species were Cymbopogon citratus (81.5 %), Melissa officinalis (77.7 %), Aloysia citriodora (66.6 %), Matricaria chamomilla (62.9 %) and Passiflora edulis (51.8 %). Scientific studies have corroborated the popular use of these plants as sedatives, but most studies are preclinical and very few have been clinical (M. chamomilla and M. officinalis), and these were mainly exploratory or were performed against placebo. In addition to efficacy data, there are also indications of toxicity for M. chamomilla and P. edulis. In conclusion, there is a great diversity of plant species used in the treatment of symptoms related to CNS disorders, and they are most frequently used as a sedative. Data indicate that M. officinalis possesses clinical efficacy in the treatment of symptoms associated with anxiety without signs of toxicity.

AbstractPrevious studies by us demonstrated the antidepressant-like and antinociceptive effects of lipophilic extracts and dimeric acyl-phloroglucinols from species of the genus Hypericum native to Southern Brazil. Uliginosin B and HC1 (an enriched phloroglucinol fraction from Hypericum caprifoliatum) are able to inhibit monoamine synaptosomal uptake without binding to the monoaminergic sites on neuronal transporters, unlike classical antidepressants. The current study aimed at investigating the action of H. caprifoliatum Cham. & Schltdl. and Hypericum polyanthemum Klotzsch ex Reichardt, Hypericaceae, cyclohexane extracts and their main component, HC1 and uliginosin B, on G protein coupled receptors by using the [35S]-guanosine-5′-O-(3-thio)triphosphate ([35S]-GTPγS) binding assay, which reveals the G protein activity. The antidepressant-like effect of acute (one or three treatments within 24 h) and repeated (five days with and without a three day wash-out) treatments with the cyclohexane extracts was evaluated using the rat forced swimming test. The [35S]-GTPγS binding to monoamines and opioid receptors stimulated by agonists was performed ex vivo in brain membranes of rats acutely or repeatedly treated with the cyclohexane extracts. The effect of HC1 and Uliginosin B on [35S]-GTPγS binding assay was performed by direct incubation with brain membranes in the absence of agonists. Their antidepressant-like effect was evaluated through the mice forced swimming test. The extracts, HC1 and Uliginosin B showed antidepressant-like effect in the forced swimming test. The acute treatments with extracts increased the [35S]-GTPγS binding stimulated by the monoamines, while after five days of treatment the [35S]-GTPγS binding was reduced even after three day wash-out. These effects are not due to HC1 or Uliginosin B interaction with the receptors, since direct incubation with these phloroglucinols did not affect [35S]-GTPγS binding to membranes. Our findings indicate that H. caprifoliatum and H. polyanthemumextracts bring about adaptive changes in monoamine receptors, which reinforces their antidepressant-like profile.

A rapid HPLC analytical method was developed and validated for the determination of the N-phenylpiperazine derivative LASSBio-579in plasma rat. Analyses were performed using a C18 column and elution with 20 mM sodium dihydrogen phosphate monohydrate - methanol. The analyte was monitored using a photodiode array detector (257 nm). Calibration curves in spiked plasma were linear over the concentration range of 0.3-8 mg/mL with determination coefficient > 0.99. The lower limit of quantification was 0.3 mg/mL. The applicability of the HPLC method for pharmacokinetic studies was tested using plasma samples obtained after administration of LASSBio-579 to Wistar rats, showing the specificity of the method.

Neste trabalho foi realizado um levantamento bibliográfico etnobotânico sobre plantas utilizadas pela população brasileira no tratamento de sinais e sintomas relacionados às infecções fúngicas. Foram citadas 409 espécies, distribuídas em 98 famílias, com maior concentração em Fabaceae e Asteraceae. Para as dez espécies mais citadas, foi realizada uma busca relativa a estudos de atividade antifúngica na base de dados MEDLINE-PubMed. Somente foram encontrados estudos para Phytolacca americana L., Rosmarinus officinalis L., Mirabilis jalapa L., Schinus molle L. Entre as dez espécies mais utilizadas, seis correspondem a espécies nativas: Anacardium occidentale L., Cecropia peltata L., Schinus molle L., Schinus terebinthinfolius Raddi, Stryphnodendron adstringens (Mart.) Coville e Tabebuia heptaphylla (Vell.) Toledo.

The aim of this work was to draw up a list of plants used by Brazilian population for the treatment of signs and symptoms related to fungal infections and to verify the existence of scientific data related to the antifungal activity in the databasis MEDLINE-PubMed. Four hundread and nine species were listed, which are distributed in ninety eight families, mainly Fabaceae and Asteraceae. Among the more frequently mentioned species (10), only four were evaluated regarding to the antifungal activity: Phytolacca americana L., Rosmarinus officinalis L., Mirabilis jalapa L. and Schinus molle L. From those ten species, six are native (Anacardium occidentale L., Cecropia peltata L., Schinus molle L., Schinus terebinthifolius Raddi, Stryphnodendron adstringens (Mart.) Coville e Tabebuia heptaphylla (Vell.) Toledo.

Schizophrenia is a devastating psychiatric illness that affects 1-2% of the world population and continues as a challenge to neuroscience. In this work, we describe an account about the historical evolution of the dopaminergic hypothesis of schizophrenia discussing, from the medicinal chemistry point of view all different classes of antipsychotic drugs, emphasizing the rational design, structure activity relationships (SAR) and physico-chemical properties related with its molecular mechanism of action.

Alguns parâmetros são apresentados para o controle de qualidade de raízes de Pfaffia glomerata e Pfaffia paniculata, utilizando suas características botânicas e químicas. Realizou-se, também, um screening farmacológico de P. glomerata direcionado às atividades relacionadas com seu uso como "tônico". O extrato etanólico das raízes de P. glomerata não apresentou atividade antiviral, antiproliferativa, antifúngica ou atividade inibitória de monoaminoxidases. A avaliação da citotoxicidade determinou que a CI50 é > 2.000 µg/mL. As principais características morfológicas e micrográficas das raízes de P. glomerata e P. paniculata descritas permitem auxiliar na sua identificação segura.

Some parameters for the quality control of P. glomerata and P. paniculata roots using their botanical and chemical characteristics are presented. It was also carried out an in vitro pharmacological screening to evaluate some biological properties of P. glomerata that could be related to its popular use as "tonic". Relating to biological assays, ethanolic extract from P. glomerata roots did not present antiviral, antiproliferative, antifungal or MAO inhibitory activities. The cytotoxicity evaluation of P. glomerata determined that IC50 is >2,000 µg/mL. The main morphological and micrographic characteristics of P. glomerata and P. paniculata roots are described in this paper in order to aid in their unequivocal identification.